Nuvectis Pharma Stock Performance
as on October 31, 2026 at 2:15 pm IST
Day's Low
Day's High
$18.20$18.92
1.52%
Downside
2.38%
Upside
52 Week's Low
52 Week's High
$5.55$29.2869.97%
Downside
58.41%
Upside
Nuvectis Pharma share price movements today
- Previous Close
- $18.57
- Open
- $18.85
- Volume
- 184.0K
- Market Cap
- $599.3M
- Day's Low - High
- $18.20 - $18.92
- 52 Week Low - High
- $5.55 - $29.28
Nuvectis Pharma Historical Returns
- 1 Month Return
- -12.07 %
- 3 Month Return
- -18.41 %
- 1 Year Return
- + 179.67 %
- 3 Year Return
- + 121.86 %
- 5 Year Return
- 0 %
Nuvectis Pharma Stock Fundamentals & Key Indicators
Check Nuvectis Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$599.3M
EPS (TTM)
-1.31
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-14.02
Industry PE ratio
-7.60
PEG Ratio
0.94
EBITDA
-28.9M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-169.47%
Nuvectis Pharma vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Nuvectis Pharma with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $599.3M | NA | -14.02 | 0.00% | 0.00% | |
| Neutral | $85.5B | -35.47% | -26.84 | -12.57% | 0.00% | |
| StrongBuy | $134.2B | 192.00% | 30.58 | 86.04% | 0.00% | |
| Buy | $83.7B | 27.94% | 19.42 | 84.86% | 0.45% |
Stock Returns calculator for Nuvectis Pharma Stock including INR - Dollar returns
The Nuvectis Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Nuvectis Pharma investment value today
Current value as on today
₹2,97,694
Returns
₹1,97,694
(+197.69%)
Returns from Nuvectis Pharma Stock
₹1,78,313 (+178.31%)
Dollar Impact
₹19,381 (+19.38%)
Analyst Recommendation on Nuvectis Pharma Stock
Based on 3 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Nuvectis Pharma. Average target price of $35.4
Nuvectis Pharma Share Price Target
Get share price movements and forecasts by analysts on Nuvectis Pharma.
What analysts predicted
47.8%UPSIDE
Target Price
$35.4
Current Price
$18.48
Analyzed by
3 Analysts
High
$39
Target
$35.40
Low
$34
Nuvectis Pharma target price $35.4, a slight upside of 47.8% compared to current price of $18.48. According to 3 analysts rating.
Indian Investors' Interest in Nuvectis Pharma Stock
Search interest for Nuvectis Pharma Stock has increased by 2% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:2% versus previous 30 day period
Nuvectis Pharma Quarterly Profit & Loss
All numbers in Millions USD
Nuvectis Pharma Annual Profit & Loss
All numbers in Millions USD
Nuvectis Pharma Quarterly Cash Flow
All numbers in Millions USD
Nuvectis Pharma Annual Cash Flow
All numbers in Millions USD
Nuvectis Pharma News & Key Events
Today's Timeline - 26 October
Mon, 06:00 PM
-Nuvectis reports positive Phase 1b data for NXP200 in gliomas, highlighting durable responses and complete responses.
Mon, 06:45 PM
-Nuvectis announces positive Phase 1b results for NXP200, showing significant efficacy in BRAF V600-mutated gliomas.
Insights on Nuvectis Pharma
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 720.2% return, outperforming this stock by 543.4%
- NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 193.3% return, outperforming this stock by 85.8%
NEGATIVE IMPACTPrice Dip
In the last 7 days, NVCT stock has moved down by -7.4%
About Nuvectis Pharma
| Organisation | Nuvectis Pharma |
| Headquarters | 1 Bridge Plaza, Fort Lee, NJ, 07024, US |
| Industry | Biotechnology |
| CEO | Ron Bentsur |
Key Management of Nuvectis Pharma
Name | Title |
|---|---|
Mr. Ron Bentsur M.B.A. | Co-Founder, Chairman, CEO & President |
Dr. Enrique Poradosu Ph.D. | Co-Founder, Executive VP, Chief Scientific & Business Officer |
Mr. Shay Shemesh | Co-Founder, Executive VP, Chief Development & Operations Officer |
Mr. Michael Carson CPA | Vice President of Finance |
FAQs
What is Nuvectis Pharma share price today?
Nuvectis Pharma share price today is $18.48 as on at the close of the market. Nuvectis Pharma share today touched a day high of $18.92 and a low of $18.20.
What is the 52 week high and 52 week low for Nuvectis Pharma share?
Nuvectis Pharma share touched a 52 week high of $29.28 on and a 52 week low of $5.55 on . Nuvectis Pharma stock price today i.e. is closed at $18.48,which is 36.87% down from its 52 week high and 232.97% up from its 52 week low.
What is Nuvectis Pharma's market capitalisation today?
Nuvectis Pharma market capitalisation is $0.00T as on .
How to invest in Nuvectis Pharma Stock (NVCT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Nuvectis Pharma on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Nuvectis Pharma Stock (NVCT) from India?
Indian investors can start investing in Nuvectis Pharma (NVCT) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Nuvectis Pharma stock (as per the Rupee-Dollar exchange rate as on ).
Based on Nuvectis Pharma share’s latest price of $18.48 as on October 31, 2026 at 8:45 am IST, you will get 0.5411 shares of Nuvectis Pharma. Learn more about
fractional shares .